# Aortic Stenosis and Cardiac Amyloidosis

> **NCT06129331** · — · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 300 (estimated)

## Conditions studied

- Cardiac Amyloidosis
- Aortic Stenosis

## Interventions

- **DRUG:** Amyloid-specific treatment
- **OTHER:** No amyloid-specific treatment

## Key facts

- **NCT ID:** NCT06129331
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-11-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06129331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06129331, "Aortic Stenosis and Cardiac Amyloidosis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT06129331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*